FindMyKOL
Clinical trialNCT02101190CompletedPhase 1Interventional

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

SponsorBial - Portela C S.A.Enrollment16Parkinson's Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the pharmacokinetics (PK) of BIA 9-1067 in patients with moderate chronic hepatic impairment and in matched healthy subjects.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Biotrial, 7-9 Rue Jean-Louis Bertrand

    Rennes, France

Russia
  • City Clinical Hospital N°3

    Moscow, Moscow, Russia

  • City Clinical Hospital N°64

    Moscow, Moscow, Russia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BIA 9-1067
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2010
Primary completion
31 May 2010
Completion
31 May 2010
Last update posted
15 Jan 2015
Registered enrollment
16
Registry id
NCT02101190
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.